Geron, University of Edinburgh Joins Hand for Human Embryonic Stem Cell Research geron ，愛丁堡大學的加入，一方面為人類胚胎幹細胞研究
Geron Corporation (www.geron.com) and the University of Edinburgh ( www.ed.ac.uk) announced today that they have entered into a collaboration to conduct preclinical safety and efficacy studies with three cell types derived from human embryonic stem cells (hESCs). geron公司（ www.geron.com ）和愛丁堡大學（ www.ed.ac.uk ）今天宣布，他們已經進入了一個合作進行臨床前安全性和療效的研究與三個類型的細胞來自人類胚胎幹細胞（ hescs ） 。
The cell types are hepatocytes for the treatment of liver failure and osteoblasts and chondrocytes for the treatment of musculoskeletal disorders, including osteoarthritis, bone fractures and osteoporosis.細胞類型是肝細胞用於治療肝功能衰竭和成骨細胞和軟骨細胞 ，用於治療肌肉骨骼疾病，包括骨性關節炎，骨骨折和骨質疏鬆症。 The studies, based at the University’s Centre for Regenerative Medicine, will be under the direction of Professor John Iredale, Dr. Phil Newsome, Dr. Brendon Noble and Professor Hamish Simpson.研究，設在該大學的中心，再生醫學，將指導下的Professor John iredale ，博士菲爾接受採訪時，博士brendon崇高和麥教授辛普森。
